ClinicalTrials.Veeva

Menu

Clinical Evaluation of i-STAT Analyzer Glucose, Hematocrit and Sodium for Capillary Samples

Abbott logo

Abbott

Status

Completed

Conditions

Analytical Performance of Sodium, Glucose and Hematocrit Assays by the i-STAT 500 (Alinity) Analyzer

Treatments

Diagnostic Test: In-vitro

Study type

Observational

Funder types

Industry

Identifiers

NCT02897154
CS-2016-0003

Details and patient eligibility

About

The objective of this study is to compare the performance of two i-STAT Analyzers in a Point-of-Care (POC) setting. The evaluation will be performed using a cartridge to test glucose, hematocrit and sodium on capillary specimens.

Full description

The clinical performance for glucose, hematocrit and sodium assays for capillary samples was evaluated for the investigational i-STAT 500 (Alinity) analyzer based on results of method comparison testing against the i-STAT 1W analyzer.

Enrollment

297 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Subject is ≥ 18 years of age
  • Subjects (or their legal representative) who are willing to voluntarily consent to the study

Exclusion criteria

  • There are no exclusion criteria

Trial design

Trial documents
2

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems